Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-30 Purchase | 2023-02-01 4:36 pm | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 4,444 | $0 | $0 | 26,768 (Direct) | View |
2020-09-01 Purchase | 2020-09-01 5:48 pm | Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO | 2,424 | $0 | $0 | 15,860 (Direct) | View |
2020-06-05 Purchase | 2020-06-09 6:19 pm | Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO | 2,500 | $0 | $0 | 13,512 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-01 Option Award | 2024-10-03 4:26 pm | N/A 2034-10-01 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 25,480 | $0 | 25,480 (Direct) | View |
2023-03-27 Option Award | 2023-03-29 4:25 pm | N/A 2033-03-27 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 34,369 | $0 | 34,369 (Direct) | View |
2021-09-13 Option Award | 2021-09-15 5:59 pm | N/A 2031-09-13 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 12,135 | $0 | 12,135 (Direct) | View |
2021-03-30 Option Award | 2021-04-01 09:33 am | N/A 2031-03-30 | Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO | 40,000 | $0 | 40,000 (Direct) | View |
2020-06-24 Option Award | 2020-06-26 4:50 pm | N/A 2030-06-24 | Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO | 32,000 | $0 | 32,000 (Direct) | View |